Arrowhead Pharmaceuticals Net Profit Margin 2006-2020 | ARWR

Current and historical net profit margin for Arrowhead Pharmaceuticals (ARWR) from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue. Arrowhead Pharmaceuticals net profit margin for the three months ending September 30, 2020 was .
Arrowhead Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-09-30 $0.09B $-0.09B -96.59%
2020-06-30 $0.12B $-0.03B -20.33%
2020-03-31 $0.14B $0.01B 6.47%
2019-12-31 $0.16B $0.05B 32.52%
2019-09-30 $0.17B $0.07B 40.24%
2019-06-30 $0.14B $0.05B 32.85%
2019-03-31 $0.10B $0.01B 9.47%
2018-12-31 $0.05B $-0.03B -62.50%
2018-09-30 $0.02B $-0.06B -323.53%
2018-06-30 $0.02B $-0.06B -366.67%
2018-03-31 $0.02B $-0.05B -195.65%
2017-12-31 $0.03B $-0.04B -116.13%
2017-09-30 $0.03B $-0.04B -112.90%
2017-06-30 $0.02B $-0.05B -209.09%
2017-03-31 $0.01B $-0.06B -453.85%
2016-12-31 $0.00B $-0.07B -1850.00%
2016-09-30 $0.00B $-0.08B inf%
2016-06-30 $0.00B $-0.08B inf%
2016-03-31 $0.00B $-0.08B inf%
2015-12-31 $0.00B $-0.09B inf%
2015-09-30 $0.00B $-0.09B inf%
2015-06-30 $0.00B $-0.09B inf%
2015-03-31 $0.00B $-0.09B inf%
2014-12-31 $0.00B $-0.07B inf%
2014-09-30 $0.00B $-0.06B inf%
2014-06-30 $0.00B $-0.05B inf%
2014-03-31 $0.00B $-0.05B inf%
2013-12-31 $0.00B $-0.04B inf%
2013-09-30 $0.00B $-0.03B inf%
2013-06-30 $0.00B $-0.02B inf%
2013-03-31 $0.00B $-0.03B inf%
2012-12-31 $0.00B $-0.02B inf%
2012-09-30 $0.00B $-0.02B inf%
2009-12-31 $0.00B $-0.01B -433.33%
2009-09-30 $0.00B $-0.02B -475.00%
2009-06-30 $0.00B $-0.03B -625.00%
2009-03-31 $0.00B $-0.03B -3000.00%
2008-12-31 $0.00B $-0.03B -1550.00%
2008-09-30 $0.00B $-0.03B -2800.00%
2008-06-30 $0.00B $-0.03B -1350.00%
2008-03-31 $0.00B $-0.03B -1033.33%
2007-12-31 $0.00B $-0.03B -1550.00%
2007-09-30 $0.00B $-0.03B -1500.00%
2007-06-30 $0.00B $-0.03B -2900.00%
2007-03-31 $0.00B $-0.02B inf%
2006-12-31 $0.00B $-0.02B inf%
2006-09-30 $0.00B $-0.02B inf%
2006-06-30 $0.00B $-0.02B inf%
2006-03-31 $0.00B $-0.01B inf%
2005-12-31 $0.00B $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.205B $0.088B
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.547B 41.72
Takeda Pharmaceutical (TAK) Japan $55.520B 10.36
Astellas Pharma (ALPMY) Japan $29.230B 18.26
Eisai (ESALY) Japan $22.154B 19.30
UCB SA (UCBJF) Belgium $21.755B 0.00
Merck (MKGAF) Germany $19.910B 26.11
Catalent (CTLT) United States $15.590B 46.63
Grifols, S.A (GRFS) Spain $12.651B 14.49
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.500B 23.81
Neurocrine Biosciences (NBIX) United States $8.951B 70.45
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.542B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.958B 12.86
IPSEN SA ADR (IPSEY) France $7.946B 0.00
Ionis Pharmaceuticals (IONS) United States $6.997B 68.55
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $6.019B 12.81
Evotec AG (EVTCY) Germany $4.852B 329.72
PTC Therapeutics (PTCT) United States $4.309B 0.00
Sage Therapeutics (SAGE) United States $4.157B 0.00
ChemoCentryx (CCXI) United States $3.872B 0.00
FibroGen (FGEN) United States $3.761B 0.00
Hypermarcas (HYPMY) Brazil $3.635B 13.37
Nektar Therapeutics (NKTR) United States $2.994B 0.00
Cronos Group (CRON) Canada $2.857B 0.00
Pacira BioSciences (PCRX) United States $2.793B 60.64
Revolution Medicines (RVMD) United States $2.767B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.671B 13.64
Corcept Therapeutics (CORT) United States $2.658B 25.71
Xencor (XNCR) United States $2.353B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.883B 16.11
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.732B 0.00
Trillium Therapeutics (TRIL) Canada $1.708B 0.00
USANA Health Sciences (USNA) United States $1.623B 14.28
Heron Therapeutics (HRTX) United States $1.611B 0.00
Translate Bio (TBIO) United States $1.356B 0.00
Endo (ENDP) Ireland $1.262B 1.92
Indivior (INVVY) United States $1.262B 15.64
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.229B 8.54
Zogenix (ZGNX) United States $1.180B 0.00
Karyopharm Therapeutics (KPTI) United States $1.120B 0.00
Ocular Therapeutix (OCUL) United States $1.105B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.060B 0.00
Tilray (TLRY) Canada $1.046B 0.00
ImmunoGen (IMGN) United States $1.001B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.861B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.823B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.774B 0.00
Esperion Therapeutics (ESPR) United States $0.768B 0.00
Radius Health (RDUS) United States $0.760B 0.00
VAXART, INC (VXRT) United States $0.685B 0.00
Collegium Pharmaceutical (COLL) United States $0.665B 39.24
Spectrum Pharmaceuticals (SPPI) United States $0.654B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.650B 33.88
Aerie Pharmaceuticals (AERI) United States $0.588B 0.00
Chinook Therapeutics (KDNY) United States $0.568B 0.00
Siga Technologies (SIGA) United States $0.559B 15.70
Organogenesis Holdings (ORGO) United States $0.557B 0.00
Flexion Therapeutics (FLXN) United States $0.546B 0.00
Ardelyx (ARDX) United States $0.538B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.493B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.447B 0.00
Akebia Therapeutics (AKBA) United States $0.445B 0.00
Molecular Templates (MTEM) United States $0.439B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.417B 0.00
TherapeuticsMD (TXMD) United States $0.397B 0.00
Innate Pharma SA (IPHYF) France $0.396B 0.00
DURECT (DRRX) United States $0.372B 0.00
Harpoon Therapeutics (HARP) United States $0.366B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.361B 9.41
Profound Medical (PROF) Canada $0.358B 0.00
Calithera Biosciences (CALA) United States $0.352B 0.00
Concert Pharmaceuticals (CNCE) United States $0.338B 0.00
KalVista Pharmaceuticals (KALV) United States $0.334B 0.00
Rafael Holdings (RFL) United States $0.331B 0.00
MEI Pharma (MEIP) United States $0.321B 0.00
Redhill Biopharma (RDHL) Israel $0.313B 0.00
CASI Pharmaceuticals (CASI) United States $0.311B 0.00
Altimmune (ALT) United States $0.306B 0.00
Summit Therapeutics (SMMT) United States $0.283B 0.00
Menlo Therapeutics (VYNE) United States $0.275B 0.00
CTI BioPharma (CTIC) United States $0.274B 0.00
Jounce Therapeutics (JNCE) United States $0.272B 0.00
Lannett Co Inc (LCI) United States $0.266B 7.02
Nature's Sunshine Products (NATR) United States $0.251B 16.15
IMV INC (IMV) Canada $0.233B 0.00
OptiNose (OPTN) United States $0.226B 0.00
Aquestive Therapeutics (AQST) United States $0.223B 0.00
Xeris Pharmaceuticals (XERS) United States $0.212B 0.00
Otonomy (OTIC) United States $0.211B 0.00
Alpine Immune Sciences (ALPN) United States $0.197B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.165B 0.00
Taiwan Liposome (TLC) Taiwan $0.159B 0.00
Heat Biologics (HTBX) United States $0.152B 0.00
Champions Oncology (CSBR) United States $0.149B 0.00
Aclaris Therapeutics (ACRS) United States $0.143B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.128B 0.00
Infinity Pharmaceuticals (INFI) United States $0.128B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.128B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.127B 0.00
Lipocine (LPCN) United States $0.104B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.103B 0.00
MediWound (MDWD) Israel $0.099B 0.00
ProPhase Labs (PRPH) United States $0.094B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.082B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.082B 0.00
KemPharm (KMPH) United States $0.081B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.081B 0.00
Biomerica (BMRA) United States $0.077B 0.00
Nutriband (NTRB) United States $0.071B 0.00
ElectroCore (ECOR) United States $0.069B 0.00
Hemispherx BioPharma (AIM) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Novan (NOVN) United States $0.067B 0.00
AgeX Therapeutics (AGE) United States $0.066B 0.00
Natural Alternatives (NAII) United States $0.066B 127.50
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.063B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.062B 0.00
India Globalization Capital (IGC) United States $0.061B 0.00
Addex Therapeutics (ADXN) Switzerland $0.061B 0.00
GTx (ONCT) United States $0.057B 0.00
Recro Pharma (REPH) United States $0.055B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 22.85
Adamis Pharmaceuticals (ADMP) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.036B 5.27
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.035B 0.00
Vical (BBI) United States $0.033B 0.00
Sundial Growers (SNDL) Canada $0.032B 0.00
IsoRay (ISR) United States $0.032B 0.00
Neos Therapeutics (NEOS) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
PolarityTE (PTE) United States $0.026B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.016B 26.50
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Shineco (TYHT) China $0.010B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00